Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release.

Antonio Gidaro Roberto ManettiAlessandro Palmerio DelitalaMark Johns SoloskiGiorgio Lambertenghi DeliliersDante CastroDavide SoldiniRoberto Castelli

Published in: Journal of clinical medicine (2022)

The increased levels of MVs in active regimens add insight into the mechanisms of hypercoagulation in MM. In addition, a role for cytokine-related thrombosis is also suggested.

Keyphrases

venous thromboembolism
end stage renal disease
multiple myeloma
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
risk factors
pulmonary embolism
peritoneal dialysis
direct oral anticoagulants
patient reported outcomes